Dr. Kristin Rojas’ paper on endocrine therapy entails how HR+ breast cancer reduces recurrence but causes adverse effects like hot flashes, bone loss, joint pain, and genitourinary syndrome of menopause (GSM), impacting adherence. Surgeons play a key role in identifying and managing these issues with evidence-based treatments, including non-hormonal medications for hot flashes, bisphosphonates for bone health, and acupuncture or duloxetine for joint pain.
Sexual health concerns, such as GSM and low libido, require a holistic approach, including avoiding irritants, using moisturizers and lubricants, and addressing pelvic floor dysfunction. While vaginal estrogen or DHEA may help, their use must be carefully considered. Non-FDA-approved treatments lack strong evidence. Surgeons should normalize discussions, encourage symptom reporting, and refer patients to specialists when needed to improve treatment adherence and quality of life.
For more information, view her paper here:
No Comments